Document Detail

Effects of transdermal clonidine in young and elderly patients with mild hypertension: evaluation by three noninvasive methods of blood pressure measurement.
MedLine Citation:
PMID:  2441166     Owner:  NLM     Status:  MEDLINE    
The efficiency of the clonidine transdermal therapeutic system was assessed in a group of patients under 35 years of age and in another group of patients over 60 years of age. The patients in both groups had mild uncomplicated hypertension. Blood pressure (BP) was measured by the three following methods: by the physician; by an automatic device at the outpatient clinic; and by the patient at home. Seventeen young patients (mean age, 26 years) and 18 elderly patients (mean age, 68.5 years) were included in a double-blind crossover study comprising four periods of 2 weeks each, during which patients were given, weekly, either placebo or one and then two transdermal clonidine patches containing 2.5 mg of the drug. In the younger group, the average systolic and diastolic BPs measured by the physician after administration of two clonidine patches were, respectively, 4.9 and 5.9 mm Hg lower than after placebo (p less than 0.05). The absolute drop was more significant in the older group (9.3 and 6.0 mm Hg; p less than 0.01). In the young group, placebo markedly reduced systolic BP (9.8 mm Hg; p less than 0.01), and comparison of the three methods of BP measurement demonstrated their great reactivity to the physician's presence. Nine young and eight elderly patients received clonidine treatment for an average duration of 9 +/- 5 months. Six cases of skin reactions occurred and limited the usefulness of the clonidine transdermal system used in this study.
X Jeunemaitre; E Ged; M B Ducrocq; F Alhenc-Gelas; P Corvol; J Menard
Related Documents :
11684376 - Effects of hormonal replacement therapy in postmenopausal hypertensive patients.
18346516 - Safety and efficacy of enzyme replacement therapy with agalsidase beta: an internationa...
12297576 - Cardiac adverse effects associated with mitoxantrone (novantrone) therapy in patients w...
20978506 - Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer ...
9400436 - Endopyelotomy for primary ureteropelvic junction obstruction: risk factors determine th...
24447846 - Contribution of functional parameters to patient-rated outcomes after surgical treatmen...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  10     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1987 Aug 
Date Detail:
Created Date:  1987-09-24     Completed Date:  1987-09-24     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  162-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Cutaneous
Blood Pressure / drug effects*
Blood Pressure Determination / methods
Clonidine / administration & dosage,  adverse effects,  pharmacology*
Dermatitis, Contact / etiology
Double-Blind Method
Hypertension / drug therapy*,  physiopathology
Middle Aged
Random Allocation
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of pindolol on neurosympathetic responsiveness, blood flow variability, and conduction in acu...
Next Document:  Effect of age on pharmacokinetics of and blood pressure responses to prazosin and terazosin.